688185 康希诺
已收盘 12-16 15:00:00
资讯
新帖
简况
康希诺跌2.50% 2020年上市募52亿中信证券保荐
中金财经 · 12-03
康希诺跌2.50% 2020年上市募52亿中信证券保荐
康希诺（688185）披露取消监事会及修订公司章程等议案获通过，11月27日股价下跌0.22%
证券之星 · 11-27
康希诺（688185）披露取消监事会及修订公司章程等议案获通过，11月27日股价下跌0.22%
康希诺：关于回购A股股份注销实施的公告
证券日报 · 11-26
康希诺：关于回购A股股份注销实施的公告
每周股票复盘：康希诺（688185）吸入用肺结核疫苗印尼启动I期临床
证券之星 · 11-16
每周股票复盘：康希诺（688185）吸入用肺结核疫苗印尼启动I期临床
康希诺(688185.SH)：吸入用结核病加强疫苗于印度尼西亚启动I期临床试验并完成首例受试者入组
智通财经 · 11-13
康希诺(688185.SH)：吸入用结核病加强疫苗于印度尼西亚启动I期临床试验并完成首例受试者入组
康希诺（688185）披露拟用公积金弥补亏损，11月11日股价下跌0.26%
证券之星 · 11-11
康希诺（688185）披露拟用公积金弥补亏损，11月11日股价下跌0.26%
每周股票复盘：康希诺（688185）拟用公积金14.5亿元弥补亏损
证券之星 · 11-09
每周股票复盘：康希诺（688185）拟用公积金14.5亿元弥补亏损
康希诺（688185）披露拟使用公积金弥补亏损，11月07日股价下跌0.26%
证券之星 · 11-07
康希诺（688185）披露拟使用公积金弥补亏损，11月07日股价下跌0.26%
康希诺（688185）披露2025年A股限制性股票激励计划首次授予结果，10月27日股价上涨0.08%
证券之星 · 10-27
康希诺（688185）披露2025年A股限制性股票激励计划首次授予结果，10月27日股价上涨0.08%
每周股票复盘：康希诺（688185）拟注销406098股并推股权激励
证券之星 · 10-26
每周股票复盘：康希诺（688185）拟注销406098股并推股权激励
康希诺公布国际专利申请：“一种重组腺病毒载体疫苗制剂及其制备方法”
证券之星 · 10-25
康希诺公布国际专利申请：“一种重组腺病毒载体疫苗制剂及其制备方法”
康希诺（688185）披露2025年A股限制性股票激励计划草案，10月20日股价上涨0.72%
证券之星 · 10-20
康希诺（688185）披露2025年A股限制性股票激励计划草案，10月20日股价上涨0.72%
每周股票复盘：康希诺（688185）选举Xuefeng YU为董事长
证券之星 · 10-19
每周股票复盘：康希诺（688185）选举Xuefeng YU为董事长
康希诺（688185）披露2025年A股限制性股票激励计划激励对象名单公示情况，10月17日股价下跌1.76%
证券之星 · 10-17
康希诺（688185）披露2025年A股限制性股票激励计划激励对象名单公示情况，10月17日股价下跌1.76%
每周股票复盘：康希诺（688185）2025年9月H股与A股股本无变动
证券之星 · 10-12
每周股票复盘：康希诺（688185）2025年9月H股与A股股本无变动
康希诺（688185）公司公告披露H股及A股股本变动情况，10月09日股价下跌1.53%
证券之星 · 10-09
康希诺（688185）公司公告披露H股及A股股本变动情况，10月09日股价下跌1.53%
康希诺公布国际专利申请：“一种重组脊髓灰质炎病毒样颗粒组合物及其制备方法和应用”
证券之星 · 09-28
康希诺公布国际专利申请：“一种重组脊髓灰质炎病毒样颗粒组合物及其制备方法和应用”
康希诺(688185.SH)拟推258万股A股限制性股票激励计划
智通财经 · 09-26
康希诺(688185.SH)拟推258万股A股限制性股票激励计划
康希诺(688185)9月19日股东户数1.79万户，较上期减少0.37%
证券之星 · 09-23
康希诺(688185)9月19日股东户数1.79万户，较上期减少0.37%
每周股票复盘：康希诺（688185）A股库存股406,098股未变动
证券之星 · 09-07
每周股票复盘：康希诺（688185）A股库存股406,098股未变动
暂无数据
公司概况
公司名称：
康希诺生物股份公司
所属行业：
医药制造业
上市日期：
2020-08-13
主营业务：
康希诺生物股份公司的主营业务是研发、生产和商业化符合中国及国际标准的创新型疫苗。公司的主要产品是MCV4、PCV13i、MCV2、Ad5-nCoV、吸入用Ad5-nCoV及XBB.1.5变异株疫苗、Ad5-EBOV。
发行价格：
209.71
{"stockData":{"symbol":"688185","market":"SH","secType":"STK","nameCN":"康希诺","latestPrice":62.84,"timestamp":1765868400000,"preClose":64.49,"halted":0,"volume":1520172,"delay":0,"changeRate":-0.0256,"floatShares":113999999,"shares":247000000,"eps":-0.575,"marketStatus":"已收盘","change":-1.65,"latestTime":"12-16 15:00:00","open":64.4,"high":64.52,"low":62.83,"amount":96151700,"amplitude":0.0262,"askPrice":62.84,"askSize":130,"bidPrice":62.83,"bidSize":18,"shortable":0,"etf":0,"ttmEps":-0.575,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765935000000},"marketStatusCode":5,"adr":0,"adjPreClose":64.49,"symbolType":"stock_kcb","openAndCloseTimeList":[[1765848600000,1765855800000],[1765861200000,1765868400000]],"highLimit":70.94,"lowLimit":58.04,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":247043801,"isCdr":false,"pbRate":3.15,"roa":"--","roe":"0.29%","epsLYR":-1.53,"committee":-0.433036,"marketValue":15524000000,"turnoverRate":0.0133,"status":1,"afterMarket":{"amount":0,"volume":0,"close":62.84,"buyVolume":0,"sellVolume":0,"time":1765870437768,"indexStatus":"已收盘 12-16 15:30:00","preClose":64.49},"hkstockBrief":{"symbol":"06185","market":"HK","secType":"STK","nameCN":"康希诺生物","latestPrice":36.74,"timestamp":1765872500007,"preClose":37.72,"halted":0,"volume":573050,"delay":0,"premium":"-47.13"},"floatMarketCap":7187000000},"requestUrl":"/m/hq/s/688185/tweets","defaultTab":"tweets","newsList":[{"id":"2588014445","title":"康希诺跌2.50% 2020年上市募52亿中信证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2588014445","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588014445?lang=zh_cn&edition=full","pubTime":"2025-12-03 17:22","pubTimestamp":1764753726,"startTime":"0","endTime":"0","summary":"中国经济网北京12月3日讯 康希诺 今日股价下跌，截至收盘报65.63元，跌幅2.50%。 康希诺于2020年8月13日在上交所科创板上市，发行数量为2480万股，发行价格209.71元/股，保荐机构为中信证券，保荐代表人为焦延延、马可；联席主承销商为中金公司，副主承销商为渤海证券。 康希诺首次公开发行股票的发行费用为2.21亿元，其中保荐及承销费用2.05亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20251203/31841808.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0188","BK0196","LU1794554557.SGD","LU2148510915.USD","LU0405327148.USD","LU0405327494.USD","BK1521","LU1328615791.USD","BK1516","BK1147","LU1720050803.USD","LU2289578879.USD","BK0276","LU1997244956.HKD","BK0239","LU1655091616.SGD","BK0183","LU1064130708.USD","LU2495084118.USD","LU1997245177.USD","LU1064131003.USD","06030","BK0012","LU1255011170.USD","LU1997245094.SGD","600030","BK0028","688185","BK1564"],"gpt_icon":1},{"id":"2586225544","title":"康希诺（688185）披露取消监事会及修订公司章程等议案获通过，11月27日股价下跌0.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586225544","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586225544?lang=zh_cn&edition=full","pubTime":"2025-11-27 22:16","pubTimestamp":1764252987,"startTime":"0","endTime":"0","summary":"截至2025年11月27日收盘，康希诺报收于68.6元，较前一交易日下跌0.22%，最新总市值为169.47亿元。该股当日开盘68.6元，最高69.36元，最低68.16元，成交额达7180.52万元，换手率为0.91%。近日，康希诺生物股份公司召开2025年第二次临时股东大会，审议通过了关于取消监事会、修订《公司章程》及其附件并办理工商变更登记的议案，修订部分公司治理制度的议案，以及使用公积金弥补亏损的议案。公告显示，本次会议表决程序合法有效，所有议案均获通过，无被否决议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700038439.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688185"],"gpt_icon":0},{"id":"2586250392","title":"康希诺：关于回购A股股份注销实施的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2586250392","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586250392?lang=zh_cn&edition=full","pubTime":"2025-11-26 21:39","pubTimestamp":1764164394,"startTime":"0","endTime":"0","summary":"证券日报网讯11月26日晚间，康希诺发布公告称，本次回购股份注销日期为2025年11月27日，股份注销数量为406，098股A股股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511263575664492.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["159982","399300","BK0239","688185"],"gpt_icon":0},{"id":"2583659452","title":"每周股票复盘：康希诺（688185）吸入用肺结核疫苗印尼启动I期临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2583659452","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583659452?lang=zh_cn&edition=full","pubTime":"2025-11-16 02:36","pubTimestamp":1763231775,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘，康希诺报收于75.08元，较上周的74.27元上涨1.09%。本周，康希诺11月14日盘中最高价报77.1元。本周关注点公司公告汇总：康希诺吸入用肺结核疫苗在印度尼西亚启动I期临床试验并完成首例受试者入组。公司公告汇总：康希诺召开2025年第二次临时股东大会，审议取消监事会及修订《公司章程》等议案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111600000568.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688185","159646","BK0239"],"gpt_icon":0},{"id":"2583355472","title":"康希诺(688185.SH)：吸入用结核病加强疫苗于印度尼西亚启动I期临床试验并完成首例受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2583355472","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583355472?lang=zh_cn&edition=full","pubTime":"2025-11-13 16:32","pubTimestamp":1763022730,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康希诺(688185.SH)发布公告，公司开发的吸入用肺结核疫苗(5型腺病毒载体)(简称“吸入用结核病加强疫苗”)近日于印度尼西亚启动I期临床试验，并完成I期临床首例受试者入组。该I期临床试验于印度尼西亚开展，目的是在18-49岁的成年人中探究接种一剂吸入用肺结核疫苗(5型腺病毒载体)的安全性和免疫原性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1368773.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康希诺(688185.SH)：吸入用结核病加强疫苗于印度尼西亚启动I期临床试验并完成首例受试者入组","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","159646","688185"],"gpt_icon":0},{"id":"2582835429","title":"康希诺（688185）披露拟用公积金弥补亏损，11月11日股价下跌0.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582835429","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582835429?lang=zh_cn&edition=full","pubTime":"2025-11-11 17:26","pubTimestamp":1762853198,"startTime":"0","endTime":"0","summary":"截至2025年11月11日收盘，康希诺报收于75.5元，较前一交易日下跌0.26%，最新总市值为186.82亿元。该股当日开盘75.81元，最高76.87元，最低74.71元，成交额达1.24亿元，换手率为1.43%。近日，康希诺生物股份公司发布2025年第二次临时股东大会会议资料，其中包含多项议案。公告显示，公司拟使用盈余公积和资本公积合计1,450,342,128.90元弥补母公司累计亏损。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111100028266.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688185","BK0239"],"gpt_icon":0},{"id":"2582861034","title":"每周股票复盘：康希诺（688185）拟用公积金14.5亿元弥补亏损","url":"https://stock-news.laohu8.com/highlight/detail?id=2582861034","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582861034?lang=zh_cn&edition=full","pubTime":"2025-11-09 04:30","pubTimestamp":1762633830,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘，康希诺报收于74.27元，较上周的79.16元下跌6.18%。本周，康希诺11月3日盘中最高价报79.82元。本周关注点公司公告汇总：康希诺拟使用公积金合计1,450,342,128.90元弥补母公司累计亏损。公司公告汇总：康希诺将于2025年11月17日召开第三季度业绩说明会。关于使用公积金弥补亏损的公告康希诺生物股份公司拟使用公积金弥补母公司累计亏损。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110900001612.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688185","BK0239"],"gpt_icon":0},{"id":"2581070024","title":"康希诺（688185）披露拟使用公积金弥补亏损，11月07日股价下跌0.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581070024","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581070024?lang=zh_cn&edition=full","pubTime":"2025-11-07 17:13","pubTimestamp":1762506820,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘，康希诺报收于74.27元，较前一交易日下跌0.26%，最新总市值为183.78亿元。该股当日开盘74.62元，最高74.88元，最低73.6元，成交额达9832.5万元，换手率为1.15%。近日，康希诺生物股份公司发布公告称，拟使用公积金弥补母公司累计亏损。该方案已获董事会、监事会审议通过，尚需股东大会审议。本次弥补亏损有助于提升投资者回报能力，推动公司高质量发展。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110700027053.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688185","BK0239"],"gpt_icon":0},{"id":"2578070647","title":"康希诺（688185）披露2025年A股限制性股票激励计划首次授予结果，10月27日股价上涨0.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578070647","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578070647?lang=zh_cn&edition=full","pubTime":"2025-10-27 22:18","pubTimestamp":1761574734,"startTime":"0","endTime":"0","summary":"截至2025年10月27日收盘，康希诺报收于74.61元，较前一交易日上涨0.08%，最新总市值为184.62亿元。近日，康希诺生物股份公司监事会发布关于2025年A股限制性股票激励计划首次授予激励对象名单的核查意见。激励对象符合相关法律法规及《2025年A股限制性股票激励计划（草案）》规定的资格条件和范围，主体资格合法有效，获授条件已成就。监事会同意以2025年10月27日为首次授予日，以41.20元/股的价格向86名激励对象授予2,054,600股限制性股票。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700036305.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159982","399300","BK0239","688185"],"gpt_icon":0},{"id":"2578957504","title":"每周股票复盘：康希诺（688185）拟注销406098股并推股权激励","url":"https://stock-news.laohu8.com/highlight/detail?id=2578957504","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578957504?lang=zh_cn&edition=full","pubTime":"2025-10-26 02:24","pubTimestamp":1761416652,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘，康希诺报收于74.55元，较上周的72.7元上涨2.54%。本周关注点公司公告汇总：康希诺拟注销回购的406,098股A股股份，注册资本将相应减少。公司公告汇总：康希诺审议通过2025年A股限制性股票激励计划及H股购股权计划。康希诺发布关于注销回购A股股份并减少注册资本暨通知债权人的公告，因未在三年期限内将全部回购股份用于员工持股或股权激励，公司拟注销回购专用证券账户中的406,098股A股股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102600000441.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688185","BK0239"],"gpt_icon":0},{"id":"2578231995","title":"康希诺公布国际专利申请：“一种重组腺病毒载体疫苗制剂及其制备方法”","url":"https://stock-news.laohu8.com/highlight/detail?id=2578231995","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578231995?lang=zh_cn&edition=full","pubTime":"2025-10-25 05:31","pubTimestamp":1761341462,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示康希诺（688185）公布了一项国际专利申请，专利名为“一种重组腺病毒载体疫苗制剂及其制备方法”，专利申请号为PCT/CN2025/088983，国际公布日为2025年10月23日。专利详情如下：图片来源：世界知识产权组织（WIPO）今年以来康希诺已公布的国际专利申请6个，较去年同期减少了33.33%。结合公司2025年中报财务数据，今年上半年公司在研发方面投入了1.48亿元，同比减20.5%。数据来源：企查查以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102500005038.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688185","BK0239","159646"],"gpt_icon":0},{"id":"2576583298","title":"康希诺（688185）披露2025年A股限制性股票激励计划草案，10月20日股价上涨0.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576583298","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576583298?lang=zh_cn&edition=full","pubTime":"2025-10-20 17:19","pubTimestamp":1760951950,"startTime":"0","endTime":"0","summary":"截至2025年10月20日收盘，康希诺报收于73.22元，较前一交易日上涨0.72%，最新总市值为181.18亿元。近日，康希诺生物股份公司发布2025年第一次临时股东大会会议资料，其中披露拟制定《2025年A股限制性股票激励计划（草案）》及其考核管理办法，并提请股东大会授权董事会办理相关事宜。此外，会议还审议了制定《2025年H股购股权计划》、向XUEFENG YU博士授予371,300份H股购股权、注销已回购但未使用的406,098股A股股份等其他议案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102000021967.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","159982","688185","399300"],"gpt_icon":0},{"id":"2576504102","title":"每周股票复盘：康希诺（688185）选举Xuefeng YU为董事长","url":"https://stock-news.laohu8.com/highlight/detail?id=2576504102","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576504102?lang=zh_cn&edition=full","pubTime":"2025-10-19 04:59","pubTimestamp":1760821147,"startTime":"0","endTime":"0","summary":"截至2025年10月17日收盘，康希诺报收于72.7元，较上周的76.3元下跌4.72%。股本股东变化：康希诺拟注销406,098股A股股份，减少注册资本。公司公告汇总康希诺H股公告显示，公司于2025年10月15日召开董事会，选举Xuefeng YU为董事长。公告由董事长Xuefeng YU及董事会成员Shou Bai CHAO等共同签署，内容涉及公司治理结构、董事会职责及管理层分工，明确各专业委员会职责范围。监事会就2025年A股限制性股票激励计划首次授予激励对象名单发布核查意见。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101900001085.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688185"],"gpt_icon":0},{"id":"2576804070","title":"康希诺（688185）披露2025年A股限制性股票激励计划激励对象名单公示情况，10月17日股价下跌1.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576804070","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576804070?lang=zh_cn&edition=full","pubTime":"2025-10-17 17:15","pubTimestamp":1760692542,"startTime":"0","endTime":"0","summary":"截至2025年10月17日收盘，康希诺报收于72.7元，较前一交易日下跌1.76%，最新总市值为179.9亿元。近日，康希诺生物股份公司监事会就公司2025年A股限制性股票激励计划首次授予激励对象名单的公示情况及核查意见发布公告。公司于2025年9月27日披露《激励计划（草案）》及相关文件，并于2025年9月29日至10月9日在内部公示激励对象姓名及职务，公示期不少于10天，期间监事会未收到任何异议。名单信息真实无误，作为激励对象合法有效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101700027188.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688185","159982","BK0239","399300"],"gpt_icon":0},{"id":"2574746840","title":"每周股票复盘：康希诺（688185）2025年9月H股与A股股本无变动","url":"https://stock-news.laohu8.com/highlight/detail?id=2574746840","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574746840?lang=zh_cn&edition=full","pubTime":"2025-10-12 03:19","pubTimestamp":1760210351,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘，康希诺报收于76.3元，较上周的79.52元下跌4.05%。本周，康希诺10月9日盘中最高价报80.0元。康希诺当前最新总市值188.8亿元，在生物制品板块市值排名15/50，在两市A股市值排名1009/5158。H股上月底结存及本月底结存均为132,670,900股，面值人民币1元，于香港联交所上市。2025年9月期间未回购A股，库存A股406,098股系2022年2月7日至2022年12月1日期间回购并持有的股份，尚未注销。本月底法定/注册股本总额为人民币247,449,899元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101200000849.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688185","399300","159982","BK0239"],"gpt_icon":0},{"id":"2574859161","title":"康希诺（688185）公司公告披露H股及A股股本变动情况，10月09日股价下跌1.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574859161","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574859161?lang=zh_cn&edition=full","pubTime":"2025-10-09 23:08","pubTimestamp":1760022499,"startTime":"0","endTime":"0","summary":"截至2025年10月9日收盘，康希诺报收于78.3元，较前一交易日下跌1.53%，最新总市值为193.75亿元。近日，康希诺生物股份公司披露了截至2025年9月30日的证券变动月报表。公告显示，公司H股和A股的法定/注册股本均无变动。H股上月底结存及本月底结存均为132,670,900股，面值人民币1元，于香港联交所上市。2025年9月期间未回购A股，库存A股406,098股系2022年2月7日至2022年12月1日期间回购并持有的股份，尚未注销。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025100900035046.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688185","399300","159982","BK0239"],"gpt_icon":0},{"id":"2570081892","title":"康希诺公布国际专利申请：“一种重组脊髓灰质炎病毒样颗粒组合物及其制备方法和应用”","url":"https://stock-news.laohu8.com/highlight/detail?id=2570081892","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570081892?lang=zh_cn&edition=full","pubTime":"2025-09-28 05:12","pubTimestamp":1759007557,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示康希诺（688185）公布了一项国际专利申请，专利名为“一种重组脊髓灰质炎病毒样颗粒组合物及其制备方法和应用”，专利申请号为PCT/CN2025/083811，国际公布日为2025年9月25日。专利详情如下：图片来源：世界知识产权组织（WIPO）今年以来康希诺已公布的国际专利申请5个，较去年同期减少了37.5%。结合公司2025年中报财务数据，今年上半年公司在研发方面投入了1.48亿元，同比减20.5%。数据来源：企查查以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092800001181.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688185","BK0239"],"gpt_icon":0},{"id":"2570888480","title":"康希诺(688185.SH)拟推258万股A股限制性股票激励计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2570888480","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570888480?lang=zh_cn&edition=full","pubTime":"2025-09-26 19:56","pubTimestamp":1758887788,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康希诺(688185.SH)披露2025年A股限制性股票激励计划(草案)，拟向激励对象授予258万股限制性股票，约占2025年A股激励计划草案公告时公司股本总额的1.04%。其中首次授予206.55万股，首次授予的激励对象人数共计87人，授予价格(含预留)为41.20元/股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1350073.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康希诺(688185.SH)拟推258万股A股限制性股票激励计划","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159982","399300","BK0239","688185"],"gpt_icon":0},{"id":"2569795379","title":"康希诺(688185)9月19日股东户数1.79万户，较上期减少0.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2569795379","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569795379?lang=zh_cn&edition=full","pubTime":"2025-09-23 17:06","pubTimestamp":1758618394,"startTime":"0","endTime":"0","summary":"证券之星消息，近日康希诺披露，截至2025年9月19日公司股东户数为1.79万户，较9月10日减少66.0户，减幅为0.37%。在生物制品行业个股中，康希诺股东户数低于行业平均水平，截至9月19日，生物制品行业平均股东户数为3.42万户。从股价来看，2025年9月10日至2025年9月19日，康希诺区间跌幅为4.45%，在此期间股东户数减少66.0户，减幅为0.37%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092300026912.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688185","BK0239"],"gpt_icon":0},{"id":"2565439365","title":"每周股票复盘：康希诺（688185）A股库存股406,098股未变动","url":"https://stock-news.laohu8.com/highlight/detail?id=2565439365","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565439365?lang=zh_cn&edition=full","pubTime":"2025-09-07 05:05","pubTimestamp":1757192717,"startTime":"0","endTime":"0","summary":"截至2025年9月5日收盘，康希诺报收于82.9元，较上周的82.44元上涨0.56%。本周关注点公司公告汇总：康希诺A股库存股406,098股，本月无增减。公司公告汇总康希诺生物股份公司截至2025年8月31日的证券变动月报表显示，公司H股和A股的法定/注册股本均无变动。已发行股份方面，H股无变动；A股已发行股份为114,372,901股，库存股份数目为406,098股，本月无增减。本月底法定/注册股本总额为人民币247,449,899元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090700000993.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159982","688185","399300","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765930472336,"stockEarnings":[{"period":"1week","weight":-0.0413},{"period":"1month","weight":-0.163},{"period":"3month","weight":-0.2355},{"period":"6month","weight":0.0863},{"period":"1year","weight":-0.0194},{"period":"ytd","weight":0.0293}],"compareEarnings":[{"period":"1week","weight":-0.0217},{"period":"1month","weight":-0.0415},{"period":"3month","weight":-0.0133},{"period":"6month","weight":0.1376},{"period":"1year","weight":0.1295},{"period":"ytd","weight":0.1411}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"康希诺生物股份公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"17290人(较上一季度增加0.19%)","perCapita":"6614股","listingDate":"2020-08-13","address":"天津市东丽区经济技术开发区西区南大街185号西区生物医药园四层401-420","registeredCapital":"24704万元","survey":" 康希诺生物股份公司的主营业务是研发、生产和商业化符合中国及国际标准的创新型疫苗。公司的主要产品是MCV4、PCV13i、MCV2、Ad5-nCoV、吸入用Ad5-nCoV及XBB.1.5变异株疫苗、Ad5-EBOV。","listedPrice":209.71},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康希诺(688185)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康希诺(688185)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康希诺,688185,康希诺股票,康希诺股票老虎,康希诺股票老虎国际,康希诺行情,康希诺股票行情,康希诺股价,康希诺股市,康希诺股票价格,康希诺股票交易,康希诺股票购买,康希诺股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康希诺(688185)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康希诺(688185)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}